Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients

Journal of the National Cancer Institute

Volumn 92, Issue 22, 2000, Pages 1841-1847

  Soufir, Nadem ^a   Daya Grosjean, Leela ^c   De La Salmonière, Pauline ^b   Moles, Jean Pierre ^d   Dubertret, Louis ^a   Sarasin, Alain ^c   Basset Seguin, Nicole ^a,b  

^a INSERM   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c CNRS   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN P14 ARF; PROTEIN P16; PROTEIN P16INK4A; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; DNA REPAIR; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN CARCINOMA; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION; XERODERMA PIGMENTOSUM;

EID: 0034669071     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.22.1841     Document Type: Article

References (50)

1. Xeroderma pigmentosum
2. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases
3. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C
4. Specific UV-induced mutation spectrum in the p53 gene Of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients
5. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients
6. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum
7. Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes
8. Role of the alternative INK4A proteins in human keratinocyte senescence: Evidence for the specific inactivation of p16INK4A upon immortalization
9. Association of CDKN2A/pl6INK4A with human head and neck keratinocyte replicative senescence: Relationship of dysfunction to immortality and neoplasia
10. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss
11. Role of the INK4a locus in tumor suppression and cell mortality
12. Tumor suppression at the INK4a locus mediated by the alternative reading frame product p19(ARF)
13. The INK4A/ARF locus and its two gene products
14. p16 inhibition of transformed and primary squamous epithelial cells
15. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro
16. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
17. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
18. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
19. The ARF/p53 pathway
20. The pI6INK4a/CDKN2A tumor suppressor and its relatives
21. Accumulation of p16CDKN2A in response to ultraviolet irradiation correlates with late S-G(2)-phase cell cycle delay
22. P16 UV mutations in skin epithelial tumours
23. Novel complementation assays for DNA repair-deficient cells. Transient and stable expression of DNA repair genes
24. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta
25. PCR-SSCP: A method for detection of mutations
26. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group
27. Germline mutations in the pl6INK4a binding domain of CDK4 in familial melanoma
28. Identification of CDK4 sequences involved in cyclin D1 and p16 binding
29. Fisher's Exact Test: An easy-to-use statistical test lor comparing outcomes
30. Mutations of the INK4a locus in squamous cell carcinomas of human skin
31. Lack of mutation in the INK4a locus in basal cell carcinomas
32. CDKN2A (p16INK4A) somatic and germline mutations
33. Compilation of somatic mutations of the CDKN2 gene in human cancers: Non-random distribution of base substitutions
34. Analysis of p16INK4a and its interaction with CDK4
35. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
36. p53 gene mutation: Software and database
37. U.v.-hypermutability of xeroderma pigmentosum cells demonstrated with a DNA-based mutation system
38. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression
39. Mutations in the CDKN2A (p16INK4a) gene in microdissected sporadic primary melanomas
40. Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient
41. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma
42. A cell cycle regulator potentially involved in genesis of many tumor types
43. Sunlight and melanoma: An answer from MTS1
44. Infrequent mutation of p16INK4 in sporadic melanoma
45. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines
46. TP53 tumor suppressor gene and skin carcinogenesis
47. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
48. p14ARF links the tumour suppressors RB and p53
49. Tumor surveillance via the ARF-p53 pathway
50. IARC Database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualisation tools